Redeye updates on Embracer after Q4-results where we have lowered estimates owing to a softer-than-expected outlook for 2025/26E, while a solid game pipeline suggests improved performance in the following years. We also updated our fair value range and the SOP-valuation on the back of the upcoming spin-off of Coffee Stain Group.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/